Posts

The GLP-1 Journey: Starting Treatment, Managing Side Effects, Preserving Muscle, Maintaining Results and Planning for Discontinuation

Image
OneDayMD Research Team · Updated October 13, 2026 · Evidence-based health guide GLP-1-based medicines have changed the treatment of obesity and type 2 diabetes. But getting good results involves more than taking an injection or watching the number on the scale fall. Nutrition, muscle preservation, side-effect management, health monitoring and a realistic long-term plan all matter. This guide follows the full treatment journey: deciding whether medication is appropriate, preparing for treatment, navigating the first few months, protecting nutritional and musculoskeletal health, maintaining benefits and planning for situations in which treatment must or may be stopped. It covers semaglutide, liraglutide and tirzepatide, among other medicines in this therapeutic category. The available products, indications, formulations and prescribing rules differ between countries. The essential takeaways Treat obesity as a long-term healt...

GLP-1 Alternatives in 2026: Best Non-GLP-1 Weight-Loss Medications, Supplements and Natural Strategies

Image
Last updated: October 12, 2026 | Editorial review: OneDayMD Editorial Team GLP-1 alternatives include non-GLP-1 prescription weight-loss medicines, structured nutrition and exercise programs, behavioral treatment, and, for eligible people, metabolic and bariatric surgery. Some supplements may help fill nutritional gaps, but most products marketed as natural weight-loss drugs have not demonstrated effects comparable to prescription obesity medications. If you are considering an alternative to Ozempic, Wegovy, Mounjaro or Zepbound, start by identifying why you want to switch. Your best option may depend on cost, side effects, injection preferences, medical history, blood sugar control, and the amount of weight you need to lose. Key takeaway: Among established non-GLP-1 prescription options, phentermine/topiramate has demonstrated comparatively substantial weight loss in clinical evidence, but it is unsuitable for some people and requires medical supervision. Orlistat ...